TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Metoclopramide to Improve Lactogenesis II in Diabetic Women: a Randomized Controlled Trial
Brief Summary: Early use of oral maxalon can hasten and improve the establishment of breastfeeding in diabetic mothers after preterm and term deliveries.

Maxolon promotes breastfeeding by working on the central nervous system which increases the milk producing hormone, prolactin which in turn helps to increase the milk supply for breastfeeding. Successful early breastfeeding establishment is important for continued breastfeeding.


Options:
A: Arm Label: Standard care plus metformin; Type: EXPERIMENTAL; Interventions: Behavioral: Standard care, Drug: Metformin | Arm Label: Standard Care plus placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard care, Drug: Placebo | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard Care plus placebo, Standard care plus metformin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Standard care plus metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Standard Care plus placebo
B: Arm Label: a; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metoclopramide (Maxolon) | Arm Label: b; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: c; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metoclopramide (Maxolon) | Arm Label: d; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoclopramide (Maxolon); Assigned to Arm(s): a, c | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): b, d
C: Arm Label: Still-Tee; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Still-Tee | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Still-Tee | Arm Label: Water; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Still-Tee; Assigned to Arm(s): Placebo, Still-Tee
D: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cognitive Benefits of Treating Apnea in Dementia
Brief Summary: The purpose of this study is to determine whether treating sleep apnea with continuous positive airway pressure would result in improvements in cognition in patients with Alzheimer's disease.


Options:
A: Arm Label: Standard CPAP follow-up; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard CPAP monitoring | Arm Label: Telemedicine CPAP follow-up; Type: EXPERIMENTAL; Interventions: Other: Telemedicine CPAP monitoring (webpage and televisit) | Intervention Type: OTHER; Name: Telemedicine CPAP monitoring (webpage and televisit); Assigned to Arm(s): Telemedicine CPAP follow-up | Intervention Type: OTHER; Name: Standard CPAP monitoring; Assigned to Arm(s): Standard CPAP follow-up
B: Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Self-Management; Type: EXPERIMENTAL; Interventions: Behavioral: Sleep Apnea Self-Management Program | Intervention Type: BEHAVIORAL; Name: Sleep Apnea Self-Management Program; Assigned to Arm(s): Self-Management | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care
C: Arm Label: Enhanced education and Enhanced follow up; Type: EXPERIMENTAL; Interventions: Other: Enhanced education, Other: Usual follow up | Arm Label: Usual education and Usual follow up; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual education, Other: Enhanced follow up | Arm Label: Enhanced education and Usual follow up; Type: EXPERIMENTAL; Interventions: Other: Enhanced education, Other: Enhanced follow up | Arm Label: Usual education with Enhanced follow up; Type: EXPERIMENTAL; Interventions: Other: Usual education, Other: Usual follow up | Intervention Type: OTHER; Name: Enhanced education; Assigned to Arm(s): Enhanced education and Enhanced follow up, Enhanced education and Usual follow up | Intervention Type: OTHER; Name: Usual education; Assigned to Arm(s): Usual education and Usual follow up, Usual education with Enhanced follow up | Intervention Type: OTHER; Name: Usual follow up; Assigned to Arm(s): Enhanced education and Enhanced follow up, Usual education with Enhanced follow up | Intervention Type: OTHER; Name: Enhanced follow up; Assigned to Arm(s): Enhanced education and Usual follow up, Usual education and Usual follow up
D: Intervention Type: DEVICE; Name: Continuous positive airway pressure; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: For cancer patients with inadequate pain relief, a switch to an alternative opioid is the preferred option for symptomatic improvement. However, multiple opioids are often simultaneously administered for anecdotal reasons.

The present study isdesigned to assess the analgesic profiles of two different strategies in chronic cancer pain: the opioid rotation from oxycodone to transdermal fentanyl and the combination of oral oxycodone and transdermal fentanyl.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: oxycodone, Drug: pregabalin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxycodone, Drug: pregabalin | Intervention Type: DRUG; Name: oxycodone; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): A, B
B: Arm Label: Oxycodone Hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone Hydrochloride | Arm Label: Morphine Sulphate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulphate | Intervention Type: DRUG; Name: Oxycodone Hydrochloride; Assigned to Arm(s): Oxycodone Hydrochloride | Intervention Type: DRUG; Name: Morphine Sulphate; Assigned to Arm(s): Morphine Sulphate
C: Intervention Type: DRUG; Name: oxycodone fentanyl; Assigned to Arm(s): N/A
D: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Oxycodone; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Fentanyl; Type: EXPERIMENTAL; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: For cancer patients with inadequate pain relief, a switch to an alternative opioid is the preferred option for symptomatic improvement. However, multiple opioids are often simultaneously administered for anecdotal reasons.

The present study isdesigned to assess the analgesic profiles of two different strategies in chronic cancer pain: the opioid rotation from oxycodone to transdermal fentanyl and the combination of oral oxycodone and transdermal fentanyl.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: oxycodone, Drug: pregabalin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxycodone, Drug: pregabalin | Intervention Type: DRUG; Name: oxycodone; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): A, B
B: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Oxycodone; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Fentanyl; Type: EXPERIMENTAL; Interventions: Drug: Fentanyl | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Fentanyl; Assigned to Arm(s): Fentanyl | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone
C: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
D: Intervention Type: DRUG; Name: oxycodone fentanyl; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Brief Summary: The purpose of this study is to compare 23 mg donepezil sustained release (SR) to the currently marketed formulation of 10 mg donepezil immediate release (IR) in patients with moderate to severe Alzheimer's disease.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil SR 23 mg) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil IR 10 mg) | Intervention Type: DRUG; Name: Aricept (donepezil SR 23 mg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aricept (donepezil IR 10 mg); Assigned to Arm(s): 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Memantine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Donepezil | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Donepezil; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: SB-742457; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): N/A
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: donepezil | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Brief Summary: The purpose of this study is to compare 23 mg donepezil sustained release (SR) to the currently marketed formulation of 10 mg donepezil immediate release (IR) in patients with moderate to severe Alzheimer's disease.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil SR 23 mg) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil IR 10 mg) | Intervention Type: DRUG; Name: Aricept (donepezil SR 23 mg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aricept (donepezil IR 10 mg); Assigned to Arm(s): 2
B: Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): N/A
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Memantine | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
D: Intervention Type: DRUG; Name: memantine; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind Cross-over Randomized Controlled Trial Comparing Letrozole Versus Clomifene Citrate for Ovulation Induction in Women With Polycystic Ovarian Syndrome
Brief Summary: The primary aim of the study is to assess the efficacy of letrozole as an ovulation induction agent and to test the hypothesis that letrozole will generate better pregnancy rates with fewer multiple pregnancies and higher live birth rate than the current standard agent, clomifene citrate in anovular infertile women with polycystic ovarian syndrome.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clomiphene citrate | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Intervention Type: DRUG; Name: Clomiphene citrate; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): B
B: Arm Label: Pre-treatment acupuncture + letrozole; Type: EXPERIMENTAL; Interventions: Other: Pre-treatment acupuncture, Drug: Letrozole | Arm Label: Letrozole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Intervention Type: OTHER; Name: Pre-treatment acupuncture; Assigned to Arm(s): Pre-treatment acupuncture + letrozole | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): Letrozole, Pre-treatment acupuncture + letrozole
C: Arm Label: Personalized acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Fixed acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Letrozole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Arm Label: Placebo letrozole; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo letrozole | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Fixed acupuncture, Personalized acupuncture | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): Letrozole | Intervention Type: DRUG; Name: Placebo letrozole; Assigned to Arm(s): Placebo letrozole
D: Arm Label: Clomiphene citrate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clomifene citrate | Arm Label: Letrozole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): Letrozole | Intervention Type: DRUG; Name: Clomifene citrate; Assigned to Arm(s): Clomiphene citrate

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Gilles de la Tourette Syndrome by Bilateral Stimulation of the Internal Part of the Globus PALLIDUS
Brief Summary: The aim of this study is to evaluate the efficacy and safety of bilateral pallidal stimulation in patients with a severe form of Gilles de la Tourette syndrome.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Deep brain stimulation | Intervention Type: DEVICE; Name: Deep brain stimulation; Assigned to Arm(s): 1
B: Intervention Type: DEVICE; Name: high frequency stimulation; Assigned to Arm(s): N/A
C: Arm Label: DBS Off first; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral GPi Deep Brain Stimulation | Arm Label: DBS On First; Type: EXPERIMENTAL; Interventions: Procedure: Bilateral GPi Deep Brain Stimulation | Intervention Type: PROCEDURE; Name: Bilateral GPi Deep Brain Stimulation; Assigned to Arm(s): DBS Off first, DBS On First
D: Arm Label: Continuous Deep Brain Stimulation (DBS); Type: EXPERIMENTAL; Interventions: Device: Continuous DBS | Arm Label: Responsive Brain Stimulation (RBS Setting); Type: EXPERIMENTAL; Interventions: Device: Responsive Brain Stimulation (RBS Setting) | Intervention Type: DEVICE; Name: Continuous DBS; Assigned to Arm(s): Continuous Deep Brain Stimulation (DBS) | Intervention Type: DEVICE; Name: Responsive Brain Stimulation (RBS Setting); Assigned to Arm(s): Responsive Brain Stimulation (RBS Setting)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 1 Study of Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
Brief Summary: Combined the chemoembolization and Radiofrequency ablation for the hepatocellular carcinoma greater than 3 cm,the ablation volume of coagulation necrosis can be significantly increased,which may be enable effective treatment of patients with HCC greater than 3 cm.


Options:
A: Intervention Type: PROCEDURE; Name: chemoembolization ,Radiofrequency ablation; Assigned to Arm(s): N/A
B: Arm Label: Yttrium-90 radioembolization (90Y-RE); Type: ACTIVE_COMPARATOR; Interventions: Drug: 90Y-RE | Arm Label: Transarterial chemoembolization with drug eluting beads; Type: ACTIVE_COMPARATOR; Interventions: Drug: TACE-DEB | Intervention Type: DRUG; Name: TACE-DEB; Assigned to Arm(s): Transarterial chemoembolization with drug eluting beads | Intervention Type: DRUG; Name: 90Y-RE; Assigned to Arm(s): Yttrium-90 radioembolization (90Y-RE)
C: Arm Label: Sorafenib (Nexavar, BAY43-9006); Type: EXPERIMENTAL; Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sorafenib (Nexavar, BAY43-9006); Assigned to Arm(s): Sorafenib (Nexavar, BAY43-9006) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Sorafenib (Nexavar, BAY43-9006) + TACE; Type: EXPERIMENTAL; Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) | Arm Label: Placebo + TACE; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sorafenib (Nexavar, BAY43-9006); Assigned to Arm(s): Sorafenib (Nexavar, BAY43-9006) + TACE | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + TACE

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Dementia Home Care Project: a Randomised Controlled Trial to Evaluate the Effectiveness of a Home Care Program for Supporting Caregivers of Persons With Dementia in Developing Countries: a Randomised Controlled Trial From Goa, India
Brief Summary: The aim of this trial was to apply a home based, flexible, stepped-care intervention designed to improve the awareness and knowledge of family caregivers regarding dementia, to maximise their caregiving resources and to improve their caregiving skills. A Randomized Controlled Trial (RCT) will be used to evaluate the same wherein the intervention group will get the services immediately and the control arm would receive the same after a period of 6 months.


Options:
A: Arm Label: FSI-ECD; Type: EXPERIMENTAL; Interventions: Behavioral: Family Strengthening Intervention for Early Childhood Development | Arm Label: Control; Type: OTHER; Interventions: Other: Community Health Worker Routine | Intervention Type: BEHAVIORAL; Name: Family Strengthening Intervention for Early Childhood Development; Assigned to Arm(s): FSI-ECD | Intervention Type: OTHER; Name: Community Health Worker Routine; Assigned to Arm(s): Control
B: Arm Label: Livestock microfinance; Type: EXPERIMENTAL; Interventions: Behavioral: Livestock Microfinance | Arm Label: Delayed Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Delayed Control Group | Intervention Type: BEHAVIORAL; Name: Livestock Microfinance; Assigned to Arm(s): Livestock microfinance | Intervention Type: OTHER; Name: Delayed Control Group; Assigned to Arm(s): Delayed Control Group
C: Arm Label: Home Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home based, flexible, stepped care intervention | Arm Label: Wait-list; Type: OTHER; Interventions: Behavioral: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period. | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention; Assigned to Arm(s): Home Care | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period.; Assigned to Arm(s): Wait-list
D: Arm Label: Self Help Plus; Type: EXPERIMENTAL; Interventions: Behavioral: Self Help Plus | Arm Label: Enhanced Treatment As Usual; Type: OTHER; Interventions: Other: Enhanced Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Self Help Plus; Assigned to Arm(s): Self Help Plus | Intervention Type: OTHER; Name: Enhanced Treatment As Usual; Assigned to Arm(s): Enhanced Treatment As Usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Dementia Home Care Project: a Randomised Controlled Trial to Evaluate the Effectiveness of a Home Care Program for Supporting Caregivers of Persons With Dementia in Developing Countries: a Randomised Controlled Trial From Goa, India
Brief Summary: The aim of this trial was to apply a home based, flexible, stepped-care intervention designed to improve the awareness and knowledge of family caregivers regarding dementia, to maximise their caregiving resources and to improve their caregiving skills. A Randomized Controlled Trial (RCT) will be used to evaluate the same wherein the intervention group will get the services immediately and the control arm would receive the same after a period of 6 months.


Options:
A: Intervention Type: BEHAVIORAL; Name: care management; Assigned to Arm(s): N/A
B: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care
C: Intervention Type: BEHAVIORAL; Name: community occupational therapy in dementia; Assigned to Arm(s): N/A
D: Arm Label: Home Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home based, flexible, stepped care intervention | Arm Label: Wait-list; Type: OTHER; Interventions: Behavioral: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period. | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention; Assigned to Arm(s): Home Care | Intervention Type: BEHAVIORAL; Name: Home based, flexible, stepped care intervention after 6 months. Families will be free to choose any health care they desire during the waiting period.; Assigned to Arm(s): Wait-list

Answer: D